Research Analysts Issue Forecasts for Livent Co.’s Q2 2022 Earnings (NYSE:LTHM)

Livent Co. (NYSE:LTHMGet Rating) – B. Riley upped their Q2 2022 earnings per share (EPS) estimates for Livent in a note issued to investors on Wednesday, May 11th. B. Riley analyst L. Pipes now expects that the company will post earnings of $0.27 per share for the quarter, up from their prior forecast of $0.15. B. Riley also issued estimates for Livent’s Q3 2022 earnings at $0.34 EPS, Q4 2022 earnings at $0.34 EPS, FY2022 earnings at $1.22 EPS, Q1 2023 earnings at $0.31 EPS, Q2 2023 earnings at $0.31 EPS, Q3 2023 earnings at $0.31 EPS, Q4 2023 earnings at $0.33 EPS, FY2023 earnings at $1.27 EPS and FY2024 earnings at $1.08 EPS.

Livent (NYSE:LTHMGet Rating) last released its quarterly earnings data on Tuesday, May 3rd. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.07. Livent had a return on equity of 8.69% and a net margin of 11.56%. The company had revenue of $143.50 million for the quarter, compared to analyst estimates of $139.92 million. During the same period in the previous year, the company posted $0.02 EPS. The firm’s revenue for the quarter was up 56.5% compared to the same quarter last year.

Several other research firms have also recently weighed in on LTHM. Cowen upgraded shares of Livent from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $25.00 to $33.00 in a research report on Wednesday, May 4th. Zacks Investment Research cut shares of Livent from a “buy” rating to a “hold” rating in a research report on Friday, February 18th. Cowen upgraded shares of Livent from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 4th. TheStreet upgraded Livent from a “c” rating to a “b-” rating in a research report on Wednesday, May 4th. Finally, Bank of America upgraded Livent from an “underperform” rating to a “neutral” rating in a research report on Tuesday, February 1st. One analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $29.25.

Livent stock opened at $23.44 on Friday. The business has a 50-day simple moving average of $24.18 and a 200 day simple moving average of $25.16. Livent has a 52 week low of $16.32 and a 52 week high of $33.04. The stock has a market cap of $3.79 billion, a price-to-earnings ratio of 86.82 and a beta of 2.03. The company has a quick ratio of 1.78, a current ratio of 3.03 and a debt-to-equity ratio of 0.28.

Institutional investors have recently modified their holdings of the company. Bessemer Group Inc. lifted its holdings in Livent by 77.7% in the 4th quarter. Bessemer Group Inc. now owns 1,189 shares of the company’s stock worth $29,000 after buying an additional 520 shares during the period. GoalVest Advisory LLC purchased a new position in shares of Livent during the first quarter valued at approximately $39,000. Quadrant Capital Group LLC raised its stake in Livent by 40.7% during the first quarter. Quadrant Capital Group LLC now owns 1,583 shares of the company’s stock valued at $41,000 after buying an additional 458 shares during the last quarter. IFP Advisors Inc boosted its stake in Livent by 75.0% in the 4th quarter. IFP Advisors Inc now owns 1,750 shares of the company’s stock worth $42,000 after purchasing an additional 750 shares in the last quarter. Finally, Point72 Hong Kong Ltd bought a new position in shares of Livent in the fourth quarter worth approximately $50,000. Hedge funds and other institutional investors own 97.33% of the company’s stock.

About Livent (Get Rating)

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.

Featured Articles

Earnings History and Estimates for Livent (NYSE:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.